Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS

被引:240
作者
Meisner, M [1 ]
Tschaikowsky, K [1 ]
Palmaers, T [1 ]
Schmidt, J [1 ]
机构
[1] Univ Erlangen Nurnberg, Dept Anaesthesiol, D-91054 Erlangen, Germany
来源
CRITICAL CARE | 1999年 / 3卷 / 01期
关键词
SOFA; CRP; MODS; procalcitonin; PCT; sepsis;
D O I
10.1186/cc306
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: The relation of procalcitonin (PCT) plasma concentrations compared with C-reactive protein (CRP) was analyzed in patients with different severity of multiple organ dysfunction syndrome (MODS) and systemic inflammation. Patients and methods: PCT, CRP, the sepsis-related organ failure assessment (SOFA) score, the Acute Physiology, Age, Chronic Health Evaluation (APACHE) II score and survival were evaluated in 40 patients with systemic inflammation and consecutive MODS over a period of 15 days. Results: Higher SOFA score levels were associated with significantly higher PCT plasma concentrations (SOFA 7-12: PCT 2.62 ng/ml, SOFA 19-24: PCT 15.22 ng/ml) (median), whereas CRP was elevated irrespective of the scores observed (SOFT 7-12: CRP 131 mg/l, SOFT 19-24: CRP 135 mg/l). PCT of non-surviving patients was initially not different from that of survivors but significantly increased after the fourth day following onset of the disease, whereas CRP was not different between both groups throughout the whole observation period. Conclusions: Measurement of PCT concentrations during multiple organ dysfunction syndrome provides more information about the severity and the course of the disease than that of CRP. Regarding the strong association of PCT and the respective score systems in future studies we recommend evaluation also of the severity of inflammation and MODS when PCT concentrations were compared between different types of disease.
引用
收藏
页码:45 / 50
页数:6
相关论文
共 24 条
[1]  
Al-Nawas B, 1996, Eur J Med Res, V1, P331
[2]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[3]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[4]   LETS AGREE ON TERMINOLOGY - DEFINITIONS OF SEPSIS [J].
BONE, RC .
CRITICAL CARE MEDICINE, 1991, 19 (07) :973-976
[5]  
BRUNKHORST FM, 1997, SHOCK, V7, P124
[6]   PROCALCITONIN INCREASE AFTER ENDOTOXIN INJECTION IN NORMAL SUBJECTS [J].
DANDONA, P ;
NIX, D ;
WILSON, MF ;
ALJADA, A ;
LOVE, J ;
ASSICOT, M ;
BOHUON, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1605-1608
[7]   Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia [J].
deWerra, I ;
Jaccard, C ;
Corradin, SB ;
Chiolero, R ;
Yersin, B ;
Gallati, H ;
Assicot, M ;
Bohuon, C ;
Baumgartner, JD ;
Glauser, MP ;
Heumann, D .
CRITICAL CARE MEDICINE, 1997, 25 (04) :607-613
[8]   NUTRITION AND HIV-INFECTION [J].
GRAMLICH, LM ;
MASCIOLI, EA .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 1995, 6 (01) :2-11
[9]  
GRAMM HJ, 1995, CHIR GASTROENTERO S2, V11, P51
[10]   APACHE-II - A SEVERITY OF DISEASE CLASSIFICATION-SYSTEM [J].
KNAUS, WA ;
DRAPER, EA ;
WAGNER, DP ;
ZIMMERMAN, JE .
CRITICAL CARE MEDICINE, 1985, 13 (10) :818-829